Title of article
The Current Status of Bacillus Calmette‐Guérin Vaccine Protective Efficacy
Author/Authors
Patricia, Méndez-Samperio Escuela Nacional de Ciencias Biológicas, México - Departamento de Inmunología
Pages
4
From page
29
To page
32
Abstract
Bacillus Calmette‐Guérin (BCG) vaccine against pulmonary tuberculosis (TB)
exhibits poor protective efficacy. However, BCG is the only licensed vaccine
against human TB. This review discusses the main research progress in the field
of TB vaccine development and will summarize the current status as well as the
main challenges for the development of a safer and more efficient TB vaccine.
Keywords
BCG , Global Health , Clinical Trials , Tuberculosis , Vaccine
Journal title
Vaccine Research
Serial Year
2019
Record number
2506689
Link To Document